Upstream Bio Inc (UPB)

May 20, 2025, 7:00 AM EDT - 13 days ago

Upstream Bio Appoints Stacy Price as Chief Technology Officer

May 6, 2025, 7:00 AM EDT - 27 days ago

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

Apr 17, 2025, 5:51 PM EDT - 6 weeks ago

Upstream Bio: Verekitug, A Longer-Acting Dupixent? - Key Data Is Imminent

Mar 28, 2025, 3:56 PM EDT - 2 months ago

3 Dividend Giants To Buy As Tariffs Hit Stocks

PEP PG

Mar 12, 2025, 7:00 AM EDT - 2 months ago

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Feb 25, 2025, 8:00 AM EST - 3 months ago

Upstream Bio to Present at Upcoming March Investor Conferences

Dec 16, 2024, 1:03 PM EST - 6 months ago

Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation

Dec 16, 2024, 8:00 AM EST - 6 months ago

Upstream Bio Announces Addition to Russell 2000® Index

Nov 5, 2024, 3:09 PM EST - 7 months ago

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say

Oct 15, 2024, 4:15 PM EDT - 8 months ago

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Oct 11, 2024, 12:49 PM EDT - 8 months ago

Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut

Oct 10, 2024, 7:42 PM EDT - 8 months ago

Upstream Bio raises $255 mln in US IPO

Oct 10, 2024, 7:35 PM EDT - 8 months ago

Upstream Bio Announces Pricing of Upsized Initial Public Offering

Sep 18, 2024, 5:05 PM EDT - 9 months ago

Respiratory disorder biotech Upstream Bio files for a $100 million IPO

Sep 18, 2024, 4:06 PM EDT - 9 months ago

Upstream Bio IPO Registration Document (S-1)